Angioplasty in patients with high bleeding risk (HBR) can be a crucial clinial challenge for cardiologists. Identification and management of such patients can be quite challenging due to lack of standardization. Furthermore, there are several other challenges regarding the choice of stent and duration of dual platelet therapy post angioplasty. Therefore, striking a judicious balance between risks of ischemia and bleeding in these patients is crucial.
To address the current management stategies of angioplasty in patients with HBR, Docplexus has organized an exclusive Master Series Webinar , with Dr. Anil Kumar R on “ Angioplasty in High Bleeding Risk Patients ” on 14th July 2021 , from 3:00 PM onwards . Stay tuned for this exclusive session!
